HF
MEDS

HRT Financial’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

HRT Financial’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,556
Closed -$336K – 3769
2025
Q1 		$336K Buy
+1,556
New +$262K ﹤0.01% 1715

Other funds holding MEDS

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

HRT Financial's MEDS Position: Q2 2025 in Review

HRT Financial sold out of DataMeds AI, Inc. Common Stock (MEDS) in Q2 2025, closing a stake of 1,556 shares — an estimated $336K sold.

HRT Financial first reported a position in MEDS in Q1 2025 and held it in 1 quarter. The position peaked at $336K in Q1 2025. 6 funds tracked by Wall St. Rank hold MEDS as of Q2 2025.

  • HRT Financial reported no remaining DataMeds AI, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 1,556 DataMeds AI, Inc. Common Stock shares in Q2 2025, an estimated $336K.
  • HRT Financial first reported a position in DataMeds AI, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
  • HRT Financial's DataMeds AI, Inc. Common Stock position peaked at $336K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.